Press Release: Mergers: Commission approves acquisition of Ferrosan’s Consumer Health Care Business by Pfizer

The European Commission cleared on 10 June 2011 under the Merger Regulation the acquisition of the consumer health care business of Ferrosan Holding A/S of Denmark by Pfizer of the US. The Commission concluded that the merged company would continue to face a number of credible competitors.

The parties' activities overlap in the supply of multivitamins with minerals in a number of Member States. The Commission's examination of the proposed transaction showed that even in those Member States with the highest overlaps, the combined market shares of Pfizer and Ferrosan are in general relatively moderate, and the merged company would be constrained by a number of credible competitors.